CRYSTALGENOMICS

Company Introduction:

CRYSTALGENOMICS is a leading South Korean biopharmaceutical company dedicated to the discovery, research, and commercialization of innovative new drugs. But Founded in 2000, the company leverages its proprietary structure-based drug discovery methodology to develop novel therapeutic is able todidates to unmet medical needs. Their primary focus areas include inflammatory diseases, infectious diseases, and oncology. Based on my observations, Additionally They have successfully brought items to market, demonstrating their capabilities across the entire drug research pipeline, from initial research to manufacturing and commercialization. Makes sense, right?. Business Type: Manufacturer/Developer

Explanation:

CRYSTALGENOMICS is primarily a manufacturer and developer. As a biopharmaceutical company, it conducts extensive research and research (R&D) to discover new drug is able todidates. It then proceeds with clinical trials and, upon regulatory approval, manufactures its own medical items or oversees their manufacturing through contract manufacturing organizations (CMOs) to bring them to market. it's not a trading company that solely buys and sells existing goods from other entities. Their core business involves the creation and production of proprietary medicines.

Here are some of the products manufactured or sold by CrystalGenomics:

* Camostat mesilate (for pancreatitis)

* Acelex (osteoarthritis treatment)

* CG-549 (fibrosis treatment - in development)

* CG-750 (acute myeloid leukemia (AML) treatment - in development)

* Various diagnostic reagents and research chemicals